Hatem Soliman
哈泰姆·索利曼
MD
Associate Member, Department of Breast Oncology乳腺肿瘤学部副研究员
👥Biography 个人简介
Breast oncologist at Moffitt Cancer Center focusing on TNBC immunotherapy and neoadjuvant treatment strategies. Key investigator in immunotherapy combinations for early-stage TNBC, including neoadjuvant pembrolizumab-based regimens.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
TNBC Neoadjuvant Immunotherapy
Investigated PD-1/PD-L1 checkpoint inhibitor combinations in neoadjuvant TNBC, contributing to pathological complete response optimization and identifying predictive biomarkers for immunotherapy benefit.
Representative Works 代表性著作
Immunotherapy for Triple-Negative Breast Cancer: Emerging Role of Pembrolizumab
Clinical Breast Cancer (2022)
Comprehensive review of pembrolizumab-based neoadjuvant and metastatic TNBC strategies, detailing biomarker selection and resistance mechanisms.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 哈泰姆·索利曼 的研究动态
Follow Hatem Soliman's research updates
留下邮箱，当我们发布与 Hatem Soliman（Moffitt Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment